Skip to main content
Dingdang Health Technology Group Ltd. logo

Dingdang Health Technology Group Ltd. — Investor Relations & Filings

Ticker · 9886 HKEX Human health and social work activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2026-03-27 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9886

About Dingdang Health Technology Group Ltd.

http://www.ddjkjt.com

Dingdang Health Technology Group Ltd. is a digital healthcare services provider in China, specializing in express, on-demand pharmaceutical retail and medical consultation services through an Online-to-Offline (O2O) model. The company provides a comprehensive suite of digital healthcare solutions, including instant medicine delivery, online medical consultation, chronic disease management, and health portfolio management. Dingdang Health focuses on delivering convenient, fast, professional, and accessible medical products and services to users, aiming to facilitate the transformation and upgrade of the healthcare industry.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is the Hong Kong Stock Exchange FF305 Next Day Disclosure Return, detailing changes in issued shares and extensive listings of share repurchase transactions (Part B) and a repurchase report (Section II). This clearly constitutes a report of the company buying back its own shares. Under the classification scheme, this falls under “Transaction in Own Shares” (code: POS).
2026-03-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Stock Exchange rules detailing changes in issued shares, treasury shares, and on-market share repurchases. It reports the number of shares repurchased for cancellation, average prices, aggregate amounts, and confirmation of compliance with listing rules, which is a direct report of the company’s own share transactions. This fits the “Transaction in Own Shares” category (Code: POS).
2026-03-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Main Board/GEM Rules detailing changes in issued shares and extensive share repurchases for cancellation and holding as treasury shares. It records the company’s transactions in its own shares (on-market repurchases and treasury share movements). This aligns with the definition of Transaction in Own Shares (Code: POS).
2026-03-25 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) providing detailed schedules of changes in issued and treasury shares along with a repurchase report (Section II) including daily repurchase volumes, prices, mandates, and confirmations. It is clearly a report of the company buying back its own shares (“transaction in own shares”) and not an announcement of an AGM, financial statements, or an earnings release. This aligns with category “Transaction in Own Shares (POS)”.
2026-03-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (HKEX Form FF305) detailing changes in issued shares and treasury shares, including extensive share repurchase transactions by the issuer pursuant to the Exchange listing rules. It is not a broader financial report (e.g., Annual Report, Interim Report) or an announcement of voting, board changes, or financing. Instead, it is a report of the company’s own share transactions (buybacks). Therefore it fits the “Transaction in Own Shares” category.
2026-03-23 English
PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings Classification · 1% confidence The document is an announcement regarding the proposed adoption of amended and restated memorandum and articles of association. It mentions that these amendments will be subject to shareholder approval at the forthcoming Annual General Meeting (AGM). Since the document is an announcement of a future corporate governance change and does not contain the full proxy materials or the actual report itself, it falls under the category of general regulatory announcements.
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.